lung cancer can be classified according to cell morphology: non-small cell lung cancer (squamous cell carcinoma, adenocarcinoma, large cell carcinoma, etc.), small cell lung cancer. Among them, small cell lung cancer has the highest degree of malignancy and the worst treatment effect. The degree of non-small cell lung cancer is relatively low, and the treatment effect is relatively good. Among non-small cell lung cancer, lung adenocarcinoma has the best therapeutic effect.
Lung adenocarcinoma is a type of lung cancer. Lung adenocarcinoma is more likely to occur in women and non-smokers. Most adenocarcinomas originate from smaller bronchi and are peripheral lung cancers. There are generally no obvious clinical symptoms in the early stage, and they are often found during chest X-ray examination. It appears as a round or oval mass, which generally grows slowly, but sometimes blood transfer occurs early. Lymphatic metastasis occurs later.
Lung adenocarcinoma treatment method. Z16z
Lung adenocarcinoma has the same conventional treatment methods as other cancers: surgery and chemotherapy. If early lung adenocarcinoma can be cured by surgery, radiotherapy and chemotherapy. Compared with other lung cancers,
lung adenocarcinoma has the characteristics of high gene mutation rate. About 50% of lung adenocarcinoma patients have genetic mutations. Once a patient has a gene mutation, he can take orally targeted drugs for symptomatic treatment. The most common target and incidence of
gene mutations
Targeted therapy is a treatment method targeting the identified carcinogenic sites at the cellular molecular level. By designing corresponding therapeutic drugs, drugs entering the body will specifically select carcinogenic sites to combine and act, causing tumor cells to specifically die without affecting normal tissue cells around the tumor, so molecular targeted therapy Also known as "biological missile."
After using targeted drugs, the effect is significant, side effects are small, and the quality of life of patients can be significantly improved. Although targeted drugs also have drug resistance, in recent years, the research of targeted drugs has developed rapidly. Now the second and third generations of targeted drugs have been developed, which can solve some of the drug resistance problems and further improve survival time and quality. With the advent of targeted drugs, the five-year survival rate of advanced lung adenocarcinoma has increased significantly, and some patients can even achieve clinical cure.
Summary: After the diagnosis of lung adenocarcinoma, genetic testing is required. If there is a genetic mutation, targeted therapy can be performed under the guidance of a doctor. Correct use of targeted drugs can prolong survival time and improve quality of life. The truth about lung cancer Popular science Finding true knowledge
original is not easy, if you like my article, welcome to follow, forward and like.
